PerkinElmer buys Edico Genome processor; IMS acquires real-world evidence company;

> Edico Genome sold a Dragen Bio-IT processor to PerkinElmer ($PKI). Release

> IMS Health bought Dataline Software to expand its real-world evidence offering. Item

> A comparison of Apple Watch to a validated heart monitor suggests the wearables' data is more accurate than early reviews reported. Article

> Apple ($AAPL) provided an update on the progress of the first batch of ResearchKit apps. More

> Johnson & Johnson ($JNJ) recruited an expert panel to insulate it from social media-driven campaigns for access to experimental medicines. Piece

> Genomics England's general counsel outlined the legal issues facing the organization. Interview

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.